Clinical Trial Update: The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial investigating the effects of GLP-1 in maturity-onset diabetes of the young (MODY).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maturity-onset Diabetes of the Young

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Maturity-onset Diabetes of the Young | Phase 2, Phase 3 | Status: COMPLETED